Methods of conditioning sheet bioprosthetic tissue

Patent metadata

Field	Value
Publication number	US-12544221-B2
Application number	US-202117645936-A
Country	US
Kind code	B2
Filing date	Dec 23, 2021
Priority date	Mar 23, 2010
Publication date	Feb 10, 2026
Grant date	Feb 10, 2026

Abstract

Methods for the conditioning of bioprosthetic material employ bovine pericardial membrane. A laser directed at the fibrous surface of the membrane and moved relative thereto reduces the thickness of the membrane to a specific uniform thickness and smooths the surface. The wavelength, power and pulse rate of the laser are selected which will smooth the fibrous surface as well as ablate the surface to the appropriate thickness. Alternatively, a dermatome is used to remove a layer of material from the fibrous surface of the membrane. Thinning may also employ compression. Stepwise compression with cross-linking to stabilize the membrane is used to avoid damaging the membrane through inelastic compression. Rather, the membrane is bound in the elastic compressed state through addition cross-linking. The foregoing several thinning techniques may be employed together to achieve strong thin membranes.

First claim

What is claimed is:

1 . A method for preparing a bioprosthetic tissue, the method comprising:
treating a fixed bioprosthetic tissue with a collagen preserving agent; and reducing a thickness of a pre-determined portion of the fixed bioprosthetic tissue to produce a contoured bioprosthetic tissue; wherein the pre-determined portion of the fixed bioprosthetic tissue is less than the entire fixed bioprosthetic tissue; wherein the contoured bioprosthetic tissue has at least two areas of tissue with different thicknesses from one another; and wherein the thickness of one of the at least two areas of tissue is up to twice the thickness of another of the at least two areas of tissue.

2 . The method of claim 1 , wherein the fixed bioprosthetic tissue has been treated with a fixative.

3 . The method of claim 2 , wherein the fixative is a glutaraldehyde or a formaldehyde.

4 . The method of claim 2 , wherein the fixative is a 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) or a polyethylene glycol.

5 . The method of claim 2 , further comprising compressing the fixed bioprosthetic tissue prior to the reducing.

6 . The method of claim 5 , wherein the compressing is performed during the treating of the bioprosthetic tissue with the fixative.

7 . The method of claim 2 , wherein the treating of the bioprosthetic tissue with the fixative is performed prior to the reducing.

8 . The method of claim 1 , wherein the thickness of the pre-determined portion of the bioprosthetic tissue is in the range of about 150 microns to about 250 microns.

9 . The method of claim 1 , wherein the thickness of the pre-determined portion of the fixed bioprosthetic tissue is about 100 microns.

10 . The method of claim 1 , wherein the reducing is performed using a laser.

11 . The method of claim 10 , wherein the laser is a femtosecond laser.

12 . The method of claim 1 , wherein the collagen preserving agent comprises glycerol.

13 . The method of claim 12 , wherein the reducing is performed after treating the fixed bioprosthetic tissue with the collagen preserving agent.

14 . The method of claim 1 , wherein the reducing is performed by removing material from a fibrous side of the fixed bioprosthetic tissue.

15 . The method of claim 14 , wherein the removing is performed by ablating the fibrous side of the fixed bioprosthetic tissue using a laser.

16 . The method of claim 14 , wherein the removing is performed by shearing or milling the fibrous side of the fixed bioprosthetic tissue using a mechanical device.

17 . The method of claim 1 , wherein the reducing is performed by compressing the fixed bioprosthetic tissue.

18 . The method of claim 17 , further comprising further fixing the fixed bioprosthetic tissue during the compressing using a second fixative.

19 . The method of claim 1 , further comprising forming heart valve leaflets from the contoured bioprosthetic tissue.

20 . The method of claim 19 , wherein the forming comprises forming the heart valve leaflets so that each of the heart valve leaflets has a peripheral edge region, a free edge opposite the peripheral edge region, and a central region surrounded by the peripheral edge region and the free edge.

21 . The method of claim 19 , further comprising attaching the heart valve leaflets to one or both of a skirt or a stent to form a bioprosthetic heart valve.

22 . The method of claim 21 , further comprising packaging the bioprosthetic heart valve in a non-liquid environment.

23 . The method of claim 22 , further comprising sterilizing the bioprosthetic heart valve following the packaging.

24 . A method for preparing a bioprosthetic tissue, the method comprising:
reducing a thickness of a pre-determined portion of a fixed bioprosthetic tissue to produce a contoured bioprosthetic tissue; and treating the contoured bioprosthetic tissue with one or both of a capping agent and a reducing agent; wherein the pre-determined portion of the fixed bioprosthetic tissue is less than the entire fixed bioprosthetic tissue; wherein the contoured bioprosthetic tissue has at least two areas of tissue with different thicknesses from one another; and wherein the thickness of one of the at least two areas of tissue is up to twice the thickness of another of the at least two areas of tissue.

25 . The method of claim 24 , wherein:
treating the contoured bioprosthetic tissue comprises treating the contoured bioprosthetic tissue with at least the capping agent; and treating the contoured bioprosthetic tissue with at least the capping agent reduces the propensity of the contoured bioprosthetic tissue to calcify in vivo.

26 . The method of claim 25 , wherein treating the contoured bioprosthetic tissue with at least the capping agent caps calcification nucleation sites associated with the contoured bioprosthetic tissue.

27 . The method of claim 26 , wherein the capping agent is an ethanolamine.

28 . The method of claim 26 , further comprising treating the fixed bioprosthetic tissue with a collagen preserving agent before the reducing.

29 . The method of claim 24 , wherein:
treating the contoured bioprosthetic tissue comprises treating the contoured bioprosthetic tissue with at least the reducing agent; and treating the contoured bioprosthetic tissue with at least the reducing agent reduces the propensity of the contoured bioprosthetic tissue to calcify in vivo.

30 . The method of claim 29 , wherein the reducing agent is a borohydride.

31 . The method of claim 24 , wherein treating the contoured bioprosthetic tissue comprises treating the contoured bioprosthetic tissue with both the capping agent and the reducing agent.

32 . The method of claim 31 , further comprising treating the fixed bioprosthetic tissue with a collagen preserving agent before reducing the thickness of the predetermined portion of the fixed bioprosthetic tissue.

33 . The method of claim 32 , wherein the contoured bioprosthetic tissue is treated with the capping agent and the reducing agent after the reducing.

34 . A method for preparing a bioprosthetic tissue, the method comprising:
reducing a thickness of a pre-determined portion of a fixed bioprosthetic tissue to produce a contoured bioprosthetic tissue; wherein the pre-determined portion of the fixed bioprosthetic tissue is less than the entire fixed bioprosthetic tissue; and wherein the contoured bioprosthetic tissue has at least two areas of tissue with different thicknesses from one another.

Assignees

• Edwards Lifesciences Corp

Inventors

• Dove Jeffrey S
• Tian Bin
• Schneider Ralph
• Cohen Jeffrey S
• Jankovic Ivan
• Migliazza John F
• Wright Gregory A
• Young James M
• Campbell Louis A

Classifications

• B65B63/02

  for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles · CPC title

• B65B55/18

  by liquids or gases (B65B55/14 takes precedence) · CPC title

• A61L27/3625

  Vascular tissue, e.g. heart valves · CPC title

• A61F2250/0036

  differing in thickness · CPC title

• A61F2/2418

  Scaffolds therefor, e.g. support stents · CPC title